A detailed history of Vanguard Group Inc transactions in Mimedx Group, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 5,922,724 shares of MDXG stock, worth $41 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,922,724
Previous 6,567,254 9.81%
Holding current value
$41 Million
Previous $57.6 Million 20.82%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$7.61 - $8.63 $4.9 Million - $5.56 Million
-644,530 Reduced 9.81%
5,922,724 $45.6 Million
Q4 2023

Feb 14, 2024

BUY
$5.7 - $9.14 $741,564 - $1.19 Million
130,099 Added 2.02%
6,567,254 $57.6 Million
Q3 2023

Nov 14, 2023

BUY
$6.35 - $8.16 $1.59 Million - $2.05 Million
250,812 Added 4.05%
6,437,155 $46.9 Million
Q2 2023

Aug 14, 2023

BUY
$3.14 - $6.61 $272,834 - $574,342
86,890 Added 1.42%
6,186,343 $40.9 Million
Q1 2023

May 15, 2023

BUY
$2.97 - $4.81 $14,428 - $23,366
4,858 Added 0.08%
6,099,453 $20.8 Million
Q4 2022

Feb 10, 2023

BUY
$2.63 - $3.45 $199,714 - $261,982
75,937 Added 1.26%
6,094,595 $16.9 Million
Q3 2022

Nov 14, 2022

BUY
$2.71 - $4.22 $3.66 Million - $5.7 Million
1,349,728 Added 28.91%
6,018,658 $17.3 Million
Q2 2022

Aug 12, 2022

BUY
$3.17 - $5.0 $374,605 - $590,860
118,172 Added 2.6%
4,668,930 $16.2 Million
Q1 2022

May 13, 2022

BUY
$4.27 - $6.27 $214,277 - $314,641
50,182 Added 1.12%
4,550,758 $21.4 Million
Q4 2021

Feb 14, 2022

BUY
$5.7 - $8.48 $1.55 Million - $2.31 Million
272,564 Added 6.45%
4,500,576 $27.2 Million
Q3 2021

Nov 12, 2021

SELL
$5.52 - $15.83 $1.09 Million - $3.12 Million
-197,363 Reduced 4.46%
4,228,012 $25.6 Million
Q2 2021

Aug 13, 2021

BUY
$9.02 - $12.72 $39.9 Million - $56.3 Million
4,425,375 New
4,425,375 $55.4 Million

Others Institutions Holding MDXG

About MIMEDX GROUP, INC.


  • Ticker MDXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 113,609,000
  • Market Cap $787M
  • Description
  • MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary pr...
More about MDXG
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.